Suchit Jhunjhunwala is an expert in Biochemistry at Genentech Inc. (United States). Suchit Jhunjhunwala has authored 54 publications, the most recent in 2024, and is an investigator in 2 clinical trials. SLR score: 501 (community average: 125). How the SLR is computed.

LeadR Profile

Suchit Jhunjhunwala Genentech Inc. United States
501 ScienceLeadR Reputation 501
Network Map

Biochemistry

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Genentech Inc.

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 54

Citations

Citations: 12 163 1st author: 5 Last author: 4 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo.
PMID 39737928 — genes, language, neoplasms, immunotherapy, histocompatibility antigens class i, therapeutics
Nat Commun20241
Pep2Vec: An Interpretable Model for Peptide-MHC Presentation Prediction and Contaminant Identification in Ligandome Datasets
OpenAlex W4403481769
bioRxiv (Cold Spring Harbor Laboratory)20240
Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity.
PMID 38555476 — pharmaceutical preparations, genes, mhc class ii, deep learning, roc curve
Brief Bioinform20245
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.
PMID 37741832 — genes, autophagy, biological science disciplines, neoplasms, colon, immunotherapy, organoids, immunity, therapeutics, colorectal neoplasms, colonic neoplasms
Nat Commun202333
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.
PMID 37487664 — cells, genes, vaccines, cross-priming, neoplasms, immunotherapy, t-lymphocytes, receptors, pattern recognition
J Immunother Cancer20233

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1
Phase 3 1

By status:

Completed 2

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map